Related Experiment Videos
[Palliative percutaneous treatment under x-ray computed tomographic control of inoperable pulmonary aspergilloma.
Abstract:
The authors report 30 cases of the percutaneous treatment of symptomatic pulmonary aspergilloma by injection of amphotericine paste in patients who were not considered to be operable. The treated aspergillomas had developed as a sequel to bacilliary infection and pulmonary fibrosis. Surgery was contraindicated in these patients on account of severe respiratory failure. The authors specify the technique for the preparation of the paste and for the type of percutaneous injection, the aim being to obtain complete filling of the cavity and creating an anaerobic environment for the aspergillus. The contribution of this technique for the non-surgical treatment of patients appears interesting but should be carried on a larger series to identify the exact indications and the interaction with other new treatments which have just appeared.
Insights
This study explores a novel percutaneous treatment for pulmonary aspergilloma using amphotericin paste in non-operable patients. The technique shows promise for managing this fungal lung infection in high-risk individuals.
Area of Science:
- Pulmonology
- Interventional Radiology
- Mycology
Background:
- Pulmonary aspergilloma is a serious fungal infection, often complicating conditions like tuberculosis and lung fibrosis.
- Surgical intervention is frequently not feasible in patients with severe respiratory compromise.
Purpose of the Study:
- To evaluate the efficacy and technique of percutaneous pulmonary aspergilloma treatment using amphotericin paste.
- To assess this minimally invasive approach in patients unsuitable for surgery.
Main Methods:
- Percutaneous injection of amphotericin paste into 30 symptomatic pulmonary aspergillomas.
- Detailed description of paste preparation and injection technique to ensure cavity obliteration and create an anaerobic environment.
Main Results:
- Successful percutaneous treatment was achieved in 30 patients with pulmonary aspergilloma.
- The technique aimed for complete cavity filling and an anaerobic environment to inhibit Aspergillus growth.
Conclusions:
- Percutaneous treatment with amphotericin paste offers a potential non-surgical option for pulmonary aspergilloma.
- Further studies with larger cohorts are needed to define indications and interactions with new therapies.